Serum chemokine IL-8 acts as a biomarker for identifying COVID-19-associated persistent severe acute kidney injury

• Published in: Renal failure Vol. 46; no. 1; p. 2311316
• Main Authors: He, Zhi, Liu, Jing-jing, Ma, Shao-lei
• Format: Journal Article
• Language: English
• Published: England Taylor & Francis Ltd 01.12.2024; Taylor & Francis; Taylor & Francis Group
• Subjects: acute kidney injury; Acute Kidney Injury - diagnosis; Acute Kidney Injury - etiology; biomarker; Biomarkers; Chemokines; Clinical outcomes; Clinical Study; COVID-19; COVID-19 - complications; COVID-19 - diagnosis; Creatinine; Humans; IL-8; Interferon-inducible protein; Interleukin 8; IP-10; IP-10 protein; Kidneys; Ligands; Plasma levels; Prospective Studies; covid-19; acute kidney injury; IL-8; IP-10; biomarker

Persistent severe acute kidney injury (PS-AKI) is associated with poor clinical outcomes. Our study attempted to evaluate the diagnostic value of chemokines for early-stage PS-AKI prediction. According to the KDIGO criteria, 115 COVID-19 patients diagnosed with stage 2/3 AKI were recruited from the...